How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/anticoagulant-induced-prothrombin-deficiency.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Anticoagulant-Induced Prothrombin Deficiency — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Anticoagulant-Induced Prothrombin Deficiency (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Anticoagulant-Induced Prothrombin Deficiency, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
phytomenadione	phytomenadione	Instituto Mexicano del Seguro Social		Alpha-synuclein
Phylloquinone	Phylloquinone	Guy's and St Thomas' NHS Foundation Trust		Alpha-synuclein

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Anticoagulant-Induced Prothrombin Deficiency
Guy's and St Thomas' NHS Foundation Trust · 1 drug in Anticoagulant-Induced Prothrombin Deficiency
Instituto Mexicano del Seguro Social · 1 drug in Anticoagulant-Induced Prothrombin Deficiency

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Anticoagulant-Induced Prothrombin Deficiency:

Cite this brief

Drug Landscape (2026). Anticoagulant-Induced Prothrombin Deficiency — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/anticoagulant-induced-prothrombin-deficiency. Accessed 2026-06-10.

Anticoagulant-Induced Prothrombin Deficiency full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing